Cohort Profile: Updating the cohort profile for the MRC National Survey of Health and Development: a new clinic-based data collection for ageing research by Kuh, Diana et al.
COHORT PROFILE
Cohort Profile: Updating the cohort profile
for the MRC National Survey of Health and
Development: a new clinic-based data
collection for ageing research
Diana Kuh,
1* Mary Pierce,
1 Judith Adams,
2 John Deanfield,
3 Ulf Ekelund,
4 Peter Friberg,
5
Arjun K Ghosh,
1 Nikki Harwood,
6 Alun Hughes,
7 Peter W Macfarlane,
8 Gita Mishra,
1 Denis
Pellerin,
9 Andrew Wong,
1 Alison M Stephen,
10 Marcus Richards,
1y and Rebecca Hardy
1y on behalf of
the NSHD scientific and data collection team
1MRC Unit for Lifelong Health and Ageing, Research Department of Epidemiology and Public Health, University College London,
London, UK,
2Clinical Radiology, Manchester Royal Infirmary, Oxford Road, Manchester, UK,
3Vascular Physiology Unit, Institute
of Child Health, University College London, London, UK,
4MRC Epidemiology Unit, Cambridge, UK,
5Cardiovacular Institute,
Sahlgrenska University Hospital, Go ¨teborg, Sweden,
6Wellcome Trust Clinical Research Facility Manchester, Manchester, UK,
7International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, London, UK,
8Institute of
Cardiovascular & Medical Sciences, University of Glasgow, Glasgow, UK,
9Department of Echocardiography, The Heart Hospital,
London, UK and
10MRC Human Nutrition Research, Cambridge, UK
*Corresponding author. MRC Unit for Lifelong Health and Ageing, 33 Bedford Place, London WC1B 5JU.
E-mail: d.kuh@nshd.mrc.ac.uk
yThese authors contributed equally to this work.
Accepted 26 October 2010
The MRC National Survey of
Health and Development: how did
the latest NSHD data collection
come about?
In a previously published cohort profile,
1 we showed
how the MRC National Survey of Health and
Development (NSHD), the oldest of the British birth
cohort studies, has played an important role in iden-
tifying the early origins of adult health and function.
The study has a wealth of existing prospective data
from birth; and with study members now in their
early sixties and approaching conventional retirement
age, the NSHD offers the opportunity to investigate
how lifetime experience and exposures affect the
chance of healthy ageing and reduction of functional
decline and chronic disease in later life.
Ageing populations, and the heterogeneity observed
among ageing individuals, pose a grand challenge to
society. We need to understand better how factors
acting across the whole of life can affect the chance
of living a long, healthy and independent life.
2,3 The
NSHD, one of the UK’s rich set of longitudinal cohort
resources, facilitates a life course approach to the
study of ageing, a strategic priority of the Medical
Research Council
4 and the other UK research councils
and funders.
5–7 Evidence is accumulating from the
NSHD and from other cohort studies with informa-
tion from birth, infancy or childhood that adult func-
tion and age-related chronic disease have their origins
in early life experience and environment and share
common risk factors operating across the life
course.
8–13 There is a growing consensus that biologic-
al ageing (a progressive, generalized impairment of
function resulting in a loss of adaptive response to
life challenges) is caused by the rate of accumulation
of molecular and cellular damage from the beginning
of life.
14 Modifiable factors (such as nutrition and
physical activity) and non-modifiable or random fac-
tors acting across the life course can alter exposure to
sources of damage, and the effectiveness of body sys-
tems for maintenance and repair.
The MRC Unit for Lifelong Health and Ageing
(LHA) was established in 2008 to maximize the sci-
entific potential of the NSHD and develop it into an
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e1interdisciplinary study of ageing. The LHA research
team and their scientific collaborators secured MRC
funding to invite study members to take part in
their first adult clinic-based data collection to obtain
new ageing outcomes, as well as repeat measures
of health, function and life circumstances, previously
collected by research nurses at home visits. Collection
of data took place in 2006–07 in a feasibility study on
10% of the NSHD sample living near the Wellcome
Trust Clinical Research Facility (CRF) Manchester,
and since 2008 has been taking place on the remain-
der of the sample at five other UK CRFs (due for
completion March 2011).
What does the follow-up at
60–64 years cover and what will
be the new areas of research?
The ageing outcomes in the latest NSHD follow-up
were chosen to facilitate the testing of life course
hypotheses that capitalized on the existing study
data, and because they represented important public
health problems or intermediate markers of such
problems thought to be potentially modifiable.
Quantitative ageing traits were preferred over binary
outcomes as they provide greater power for analysis,
which is important given that the sample contains
less than 3500 study members still alive and living
in Britain. The choice of outcomes also took into con-
sideration whether the measures would be sufficiently
attractive to induce study members in their early
sixties to travel a considerable distance for a clinical
assessment.
For this data collection between ages 60 and 64
years, we chose to focus on physical and cognitive
capability, the capacity to undertake the physical
and mental tasks of daily living, as measured by phys-
ical performance tests (such as grip strength, chair
rises, standing balance) and cognitive performance
tests (such as verbal memory and information pro-
cessing). These tests reflect underlying ageing pro-
cesses rather than specific diseases per se; are the
foundation for continued independence and quality
of life, as we grow older; and predict future risk of
disability, disease, morbidity and mortality.
15–18
We also chose to study the structure and function of
musculoskeletal and cardiovascular (CV) body sys-
tems because age-related changes in these systems
threaten capability and account for a major proportion
of the disease burden in the ageing population and
because there may be opportunities to delay, if not
reverse, adverse biological changes. We hypothesize
that together these ageing outcomes co-vary in ways
that have important practical implications for daily
living, and for understanding the ageing process, the
development of frailty, disease and longevity.
The existing life course prospective data make this
cohort particularly suited to test several hypotheses,
namely: (i) early as well as adult life exposures and
risks impact on these aspects of ageing; and (ii) ex-
posure to earlier sources of risk (from gestation to
early adulthood) adds substantially to, or is depend-
ent on, the burden of mid-life risk. Our conceptual
framework is that NSHD data on earlier life charac-
teristics (such as physical growth and cognitive devel-
opment, adolescent behaviour and temperament and
lifetime socio-economic environment) and on adult
functional trajectories (such as changes in blood pres-
sure, lung function and body size) and repeat meas-
ures of health behaviours (such as diet, smoking and
physical activity) relate to these ageing outcomes via
various biological, psychological and social pathways.
The study has a wealth of life course data to eluci-
date psychological and social pathways. A priority of
this data collection was to obtain new assessments of
well-being and quality of life at an age when social
roles may be rapidly changing (for example, the
supervision of grandchildren), and when retirement,
an important life transition, is taking place.
A previous study of this cohort at age 53 years col-
lected blood biomarker information on aspects of
metabolic function (HbA1c, total and high-density
lipoprotein, triglycerides), and extracted DNA to be
used for genotyping and measures of telomere
length. Another priority was, therefore, to collect fast-
ing blood and overnight urine samples to facilitate
further study of biological pathways linking lifetime
risk factors to our ageing outcomes. Of particular
interest are markers of dysregulation of homoeostatic
equilibrium hypothesized to underlie musculoskeletal,
CV and cognitive ageing and other aspects of func-
tional decline. They include markers of chronic
inflammation, adipocyte, renal and hepatic function
and neuro-endocrine function (such as insulin
growth factors, cortisol, thyroid function and heart
rate variability).
The new data collection was designed to allow LHA
scientists and their expert collaborators to meet the
objectives of LHA’s integrated research programmes
(www.nshd.mrc.ac.uk). It also enhances the NSHD re-
source for the wider scientific community (see below).
Who is in the sample?
The MRC NSHD is the oldest of the UK national birth
cohort studies and is based on a nationally represen-
tative sample of 5362 births out of all the single,
legitimate births that took place in 1 week in March
1946 in England, Scotland and Wales.
19 The whole
sample has been followed up 23 times previously,
and, at the last visit in 1999, the sample remained
broadly representative of native born British men
and women.
19
For the new data collection, the initial target sample
at the age of 60 years was 3116, excluding 337 who
remained untraced despite attempts to trace study
members through the health authorities in 2005. Of
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died, 604 had emigrated and 669 were prior refusals.
To accommodate our scattered geographical sample,
we chose the CRFs in Manchester, Edinburgh,
Birmingham and Cardiff, as well as two CRFs in
London, and allocated the target sample to the near-
est facility. These CRFs offer high-quality research en-
vironments within or close to acute hospital facilities.
The NSHD data collection was the first co-ordinated
data collection across these clinical facilities.
A 10% sample (n¼348) of traced and untraced
study members was selected for a feasibility study.
This was a stratified random sample selected from
all target study members whose last known address
was closest to the Wellcome Trust Clinical Research
Facility (WTCRF) Manchester. The target sample was
stratified into those living 440 miles from the
WTCRF Manchester and those living further away
with equal numbers being sampled from each
group. The main aims of the feasibility study at the
WTCRF Manchester were to test: (i) what proportion
of the sample would be successfully contacted; (ii)
whether study members were prepared to come to a
clinic for an assessment and to estimate the overall
clinic response rate to within  5%; (iii) whether dis-
tance from the clinic was a deterrent to attendance;
and (iv) satisfaction with the clinic visit and
compliance with the various tests. The feasibility
study, therefore, had to involve study members who
have a lifelong experience of being part of the study
as their response was likely to be different from other
members of the population.
What has been measured?
An invitation to attend a clinic at 08.00 h on a specific
day was sent out by CRF staff with an accompanying
information brochure. Before the visit, a trained
research nurse contacted the study member by tele-
phone to discuss any concerns (health, regular medi-
cation, fasting etc.). Instructions about the visit and
how to collect the overnight urine sample, along with
urine collection equipment and a pre-assessment
questionnaire, were posted to the study members
before the visit.
Study members unwilling or unable to travel to the
CRF were offered an alternative home visit, which
had fewer assessments. Collection of other informa-
tion was achieved by an initial postal questionnaire
to update socio-demographic, socio-economic and
medical information, sent  2 months before the
CRF visits began; a pre-assessment questionnaire to
capture information on everyday function, attitudes
and life events, sent ahead and collected on the day
of the visit; and through dietary diaries and activity
monitors in the days following the visit.
The measures collected are shown in Table 1. The
supplementary data available at IJE online describe
the main fieldwork processes and the data acquisition
and duty of care protocols. A 4-day training pro-
gramme and 60-page training manual for the research
nurses and the technicians were designed and imple-
mented by the MRC LHA and Human Nutrition
Research (HNR) fieldwork teams and their key
collaborators.
Feedback to participants and their general
practitioners (GPs) about clinically relevant results is
summarized in Table 2 and detailed in the supple-
mentary data available at IJE online.
Ethical approval was given by the Central
Manchester Research Ethics Committee for the data
collection taking place in Manchester, Birmingham,
Cardiff and London. Ethical approval was given by
the Scottish A Research Ethics Committee for the
data collection taking place in Edinburgh. These ap-
provals covered the extensive duty of care protocols
that were needed because of the clinical feedback
from the assessments.
What is attrition like?
Manchester feasibility sample
The response in the feasibility sample is shown in
Table 3. Within the feasibility target sample of 348,
the postal questionnaire was returned undelivered for
13 because the study member was no longer at the
address, and 3 were found to have recently died. Of
the remaining sample of 332, 276 (83%) completed a
postal questionnaire.
The valid target sample for the clinic assessment of
the feasibility study excluded 5 who had moved out-
side the catchment area, 3 who died before the visit
and 13 where the clinic invitations were returned un-
delivered, or there was no response either to two in-
vitations or to recent birthday cards and repeated
attempts by CRF staff to make contact by telephone
failed. Of the remaining sample of 311, 241 (78%)
participated in a clinic or home visit: 190 (62.1%) at-
tended the CRF, 51 (16.4%) had a home visit and a
further 7 (2.3%) completed the pre-assessment ques-
tionnaire only. In total, 298 (85.6% of the original
target sample for the feasibility study) provided
some information to the research team.
Information from the feasibility study was used to
estimate the number of expected visits for the main
study, and for statistical power calculations. Our esti-
mated overall clinic response rate was 62.1% with a
95% confidence interval of 57.7–67.5%.
In the feasibility study, there was no difference in
the overall response rate depending on distance from
the clinic (Table 4). However, distance from the clinic
had a modest effect on the choice of clinic or home
visit; of those having a visit, 81% of those living
within 40 miles of the clinic attended the clinic com-
pared with 71% of those living further than 40 miles
away (P¼0.06). There were no differences in overall
response, or in the choice of a clinic or home visit, by
A NEW CLINIC-BASED DATA COLLECTION FOR AGEING RESEARCH e3Table 1 Measurements taken in the NSHD at the age of 60–64 years
CV assessment Vascular structure and function: carotid intima-medial thickness (IMT) and
arterial distensibility (GE Vivid-I), carotid/femoral pulse wave velocity
(Vicorder) and central blood pressure and pulse wave analysis
(Sphygmocor)
Cardiac structure and function: echocardiography (GE Vivid-I). Images
from parasternal long axis and short axis views, apical 5-chamber,
4-chamber, 3-chamber, 2-chamber and aortic views (plus conventional
and tissue Doppler in 4-chamber view).
Brachial blood pressure (Omron HEM-705), 12 lead ECG (Burdick Eclipse
850i), including 6min heart rate and respiration recordings by ECG
for heart rate variability measurements.
Musculoskeletal assessment DXA (Hologic QDR 4500 Discovery): hip (total, femoral neck, trochanter,
Ward’s), lumbar spine (L1-4), whole body and region BMD, fat and lean
mass, vertebral fracture assessment, aortic calcification score.
pQCT (Stratec XCT 2000) radius: 4% site (trabecular, cortical and
subcortical BMD), 50% site (endosteal/periosteal circumference, cortical
CS area and thickness, BMC and BMD, CS muscle and fat area, stress
strain index, moment of inertia).
Tests of functional capacity,
biological function and
anthropometric measures
Verbal memory, search speed and concentration, simple and choice reaction
time, standing balance, grip strength, chair rises, get up and go test,
spirometry.
Standing and sitting height, weight, chest, upper arm, waist and hip
circumference.
Assessment of free-living
physical activity
Five continuous days by combined heart rate and movement sensor
(Actiheart) with individual calibration.
Cardio-respiratory fitness Heart rate response to an incremental step test.
Overnight fasting 50-ml
blood sample
Thyroid-stimulating hormone (TSH), free thyroxine (T4), free
Triiodothyronine (T3) (Reflex request), insulin, sodium, potassium,
alkaline phosphatase, alanine transaminase (ALT), aspartate
transaminase (AST), g-glutamyl transferase (GGT), urea, creatinine,
urate, phosphate, total bilirubin, C-reactive protein, triglyceride, HDL
cholesterol, cholesterol, calcium, corrected calcium, total protein, albu-
min, globulin, iron, total iron binding capacity (TIBC), glucose, vitamin
C, HbA1c, full blood count (including white cell Count). DNA extraction,
lithium Heparin, EDTA, citrate and fluoride plasma and serum aliquots
stored at –808C.
Overnight fasting
urine sample
Dipstick, spun and unspun aliquots stored at –80 and –208C.
Salivary samples One salivary sample was collected at the visit and a further three during
the following 24 h (evening, next day waking and 30min later).
Scales or questions Rose angina, intermittent claudication, bronchitis, chest pain, doctor
diagnosed CVD events and test for chest pain/heart disease, osteoarthritis
symptoms, back pain, knee injuries, functional limitations, fracture
history, prescribed and non-prescribed regular medication, hospital
admissions, day surgery, outpatients.
Dietary and alcohol assessment (5-day diary), CAGE, smoking, physical
activity assessment (EPAQ2), GHQ28, the Close Person Questionnaire,
life events, SF36, Edinburgh wellbeing scale, life satisfaction, neigh-
bourhood satisfaction, spare time activities, parental death, time spent
caring for others, updated marital and fertility histories.
Household income and sources, perceived financial hardship, periods
of unemployment, household size and housing tenure, own/partner’s
occupation and work status.
e4 INTERNATIONAL JOURNAL OF EPIDEMIOLOGYgender, previously recorded physical performance or
most health indicators. There was weak evidence
that those reporting coronary heart disease and asso-
ciated hospital procedures on the postal questionnaire
were more likely to have a clinic or home visit com-
pared with others (P¼0.1). The level of educational
qualifications had the strongest effect on these re-
sponse rates, with those having no qualifications
less likely to be a participant (P<0.001) or attend a
clinic visit (P¼0.01). There were no other significant
socio-demographic differences in these response rates.
Participant satisfaction with the clinic visit was very
high; 76% were very satisfied and 21% were satisfied
with their visit to the WTCRF, many making positive
comments about the staff and the comprehensive
screening, or how special the clinic experience made
them feel. About half specifically mentioned how
valuable they found the echocardiogram, ECG and
bone scans.
Remaining sample
Based on a successful feasibility study, all remaining
members of the target sample were sent the postal
questionnaire. Overall, the response was 2452 out of
a valid sample of 3071 (80%).
All remaining members of the sample still alive and
with a known postal address in England, Scotland
Table 2 Feedback to participants and GPs
Tests Results Feedback to GP
a Feedback to Study Member (SM)
b
Blood samples
listed in Table S2
Action level Telephone call from survey
doctor (SD), results normally
faxed the day results available.
Telephone call from SD advising seeing
GP ASAP
Out of normal
range
Results posted to GP Letter with results advising seeing GP
ASAP or at next routine visit
c
Normal Letter advising results are normal
Bone scan Osteoporotic Full report sent to GP Letter advising seeing GP
Osteopenic Letter advising GP may wish to give
lifestyle advice
Normal ‘Normal’ letter
ECG criteria listed
in Table S1
Abnormal Copy of ECG annotated as
‘normal’ or ‘abnormal’
‘Abnormal’ letter to GP and letter
advising SM to visit GP
Normal ‘Normal’ letter to GP and SM
Cardiac echo Abnormal and
full echo done
Letter from CRF cardiologist
with clinical advice
Local cardiologist may send copy
of letter to SM
Normal None None
Carotid intima
media thickness
Abnormal Letter from JD advising referral
for full clinical assessment
Letter advising seeing GP
Normal None None
Blood pressure Severely raised BP results sent to GP Advised at CRF to see GP within
5 days
Moderately raised Advised at CRF to see GP within 2–3
weeks
Mildly raised Advised at CRF to see GP within 3
months
GHQ or other
documentation
Suicidal ideation
or significant
mental health
concerns
None Telephone call from research team
counsellor. SM encouraged to see GP
if appropriate.
Urine dipstix Significant blood,
glucose or
protein
None SM advised at CRF to see GP ASAP
aFeedback to GP only with SM permission. If permission not given and SMs do not agree to have survey doctor contact them
blood samples are not done.
bIf SM requests feedback (most do).
cDecision as to which letter made at blood sample monthly review meeting.
ASAP¼as soon as possible; BMC¼bone mineral content; BMD¼bone mineral density; BP¼blood pressure; CAGE¼CAGE
questionnaire; CS¼cross sectional; DXA¼dual energy X-ray absorptiometry; ECG¼electrocardiogram; GHQ¼general health
questionnaire; HDL¼high density lipoprotein.
A NEW CLINIC-BASED DATA COLLECTION FOR AGEING RESEARCH e5or Wales were invited to one of six CRFs (two in
London and one in Manchester, Edinburgh, Cardiff
and Birmingham). As of the end of September 2010,
data collection is complete in Manchester, Edinburgh
and Birmingham. Of the valid sample in these centres
of 1383, 1067 (77.1%) had a clinic or home visit: 796
(57.5%) attended the CRF, and 271 (19.6%) had a
home visit.
Data collection at the other three CRFs will be com-
pleted by the March 2011. As of the end of August
2010, 1550 clinic and 394 home visits have been
made. On the basis of the traced and responding
population for the Manchester, Edinburgh and
Birmingham catchment area, we anticipate that
there will be approximately 2176 visits in the overall
sample (1623 clinic visits and 553 home visits).
What are the main strengths and
weaknesses?
One of the weaknesses of the data collection was its
length (almost 5 years from the start of the feasibility
study to the anticipated end of the main data collec-
tion). This raised challenges of maintaining staff
skills, dealing with staff turnover, servicing and tech-
nical updates of equipment, keeping morale high and
costs contained. This length was determined by fund-
ing requirements, and because no more than two
study members a day could be accommodated by
the clinic schedule, given the time restrictions
imposed by fasting and blood sampling, the time
taken for the assessments and for participant travel,
the availability of specialist technicians and the
number of CRF study sessions available. Also, under-
taking a comprehensive health assessment on a scat-
tered geographical sample required the team to set up
six data collection centres. However, this balanced the
need to keep the travelling required by study mem-
bers to a minimum with the need for standardization
of the data collection. To maintain quality control,
equipment and training across the centres was com-
parable and, in most cases, data were acquired at the
CRFs but analysed in core laboratories (see supple-
mentary data available at IJE online). The data col-
lection was also made more complex by the increased
regulatory environment in the wake of media cover-
age of losses of government data.
To set against these limitations, this study has a
number of strengths. First is the intensive phenotyp-
ing of an already well-characterized British national
cohort. The new NSHD data set will enrich UK longi-
tudinal resources and is designed to test not only the
initial hypotheses that form LHA’s scientific strategy
with existing expert collaborators but also hypotheses
that emerge from new collaborations with the wider
scientific community.
A second strength is the collection of data by home
visit, generally by the same set of research nurses, if
the study member could not attend the clinic. This
will help to maintain the representativeness of the
NSHD study sample against the social and health
bias associated with attending the clinic. We will
report separately on the representativeness of the
complete sample, and on the factors associated with
response to the postal questionnaire and the visit. One
of the benefits of a longitudinal study is that any bias
in the remaining sample can be identified and will be
taken into account before generalizing to the UK
population of the same age.
A third strength of the study was the duty of care
protocols developed specifically for an older popula-
tion. The need to respond to clinical problems identi-
fied during the comprehensive assessment raised
ethical issues analogous to those invoked by asymp-
tomatic screening.
20 If scientists subject volunteers to
clinical research investigations, there is an imperative
to do no harm, just as there is in a clinical consult-
ation. The duty of care protocols (Table 2) required at
least 1day a week of a survey doctor on the fieldwork
team to deal with resulting queries raised by partici-
pants or their GPs. The survey doctor ensured that
participants were appropriately referred to their GP
(rather than offering advice on individual clinical
care), reassured participants, facilitated their retention
in the study, ensured appropriate clinical follow-up
where necessary, avoided unnecessary work for the
GP and avoided leaving GPs uncertain as to what to
do as a consequence of tests that they had not
ordered. While responding to queries about the results
Table 3 Manchester feasibility study: response
Manchester feasibility study No. N (%)
Feasibility sample sent postal
questionnaire
348
Postal questionnaire returned
undelivered
 13
Study member had died  3
Valid sample for postal
questionnaire
332 (100)
Postal questionnaire not returned
or not completed
56 (16.9)
Postal questionnaire completed 276 (83.1)
Moved out of catchment area  5
Study member died before visit  3
Not known at address  13
Valid sample for clinic invitation 311 (100)
Declined clinic or home visit 63 (20.3)
Self completion questionnaires
only
7 (2.3)
Home visit completed 51 (16.4)
Clinic visit completed 190 (61.1)
Information from postal and/or visit 298
e6 INTERNATIONAL JOURNAL OF EPIDEMIOLOGYof routine clinical tests that are normally seen by GPs
is straightforward, it requires considerable time and
effort. Responding to queries about clinical investiga-
tions that are not routinely reported to GPs, e.g. ca-
rotid scans, raises additional issues, as the clinical
significance and the most appropriate management
plan in an asymptomatic patient is not clear. In this
case, it is important that there is an expert who is
familiar with the investigation, and the possible clin-
ical course associated with any finding, available to
discuss the result with the GP or the participant if
required.
Table 4 Manchester feasibility study
N (row per cent) N (row per cent)
Clinic/
home/SC
Refusal/non
response P-value Clinic Home/SC P-value
N¼248 N¼63 (
2) N¼190 N¼58 (
2)
Distance from clinic
440 miles 129 (80.1) 32 (19.9) 0.9 105 (81.4) 24 (18.6) 0.06
440 miles 119 (79.3) 31 (20.7) 85 (71.4) 34 (28.6)
Missing 0 0 0 0
Gender
Male 134 (80.7) 32 (19.3) 0.6 100 (74.6) 34 (25.4) 0.4
Female 114 (78.6) 31 (21.4) 90 (79.0) 24 (21.1)
Missing 0 0 0 0
Own social class 53 years
Manual 65 (81.3) 15 (18.8) 0.2 39 (60.0) 26 (40.0) <0.001
Non-manual 164 (87.2) 24 (12.8) 141 (86.0) 23 (14.0)
Missing 19 24 10 9
Highest qualification by the age of 26 years
None 84 (69.4) 37 (30.6) <0.001 55 (65.5) 29 (34.5) 0.01
Up to GCE 69 (89.6) 8 (10.4) 56 (81.2) 13 (18.8)
A level and above 86 (86.0) 14 (14.0) 72 (83.7) 14 (16.3)
Missing 9 4 7 2
Employment (from postal questionnaire)
Full time 75 (86.2) 12 (13.8) 0.8 57 (76.0) 18 (24.0) 0.2
Paid part-time 46 (85.2) 8 (14.8) 41 (89.1) 5 (10.9)
Not in paid work 101 (82.8) 21 (17.2) 77 (76.2) 24 (23.8)
Missing 26 22 15 11
Hospital procedures for CHD and doctor-diagnosed CHD (from postal questionnaire)
No 174 (82.5) 37 (17.5) 0.1 135 (77.6) 39 (22.4) 0.6
Yes 52 (91.2) 5 (8.8) 42 (80.8) 10 (19.2)
Missing 22 21 13 9
Doctor diagnosed BP problems (from postal questionnaire)
No 169 (84.9) 30 (15.1) 0.6 135 (79.9) 34 (20.1) 0.3
Yes 57 (82.6) 12 (17.4) 42 (73.7) 15 (26.3)
Missing 22 21 13 9
Grip strength at the age of 53 years
Lowest quartile 55 (85.9) 9 (14.1) 0.6 42 (76.4) 13 (23.6) 0.8
2nd to 4
th quartile 158 (83.2) 32 (16.8) 123 (77.9) 35 (22.2)
Missing 35 22 25 10
Overall response and choice of clinic or home visit by study member characteristics.
SC¼self completion.
A NEW CLINIC-BASED DATA COLLECTION FOR AGEING RESEARCH e7A final strength of this study is increased capacity
building in the research community. It has developed
the skill base of the research nurses in the UK CRFs
and led to the development of home visit services, at a
time when demand for including biological measures
in health and social surveys is high and supply of
suitably trained nurses limited. The model of scientific
collaboration has also developed the skill base of the
research team and has enabled specialist measures to
be collected within reasonable costs.
This pioneering clinic data collection may provide a
model for other UK national birth cohort studies
which, like the NSHD, have traditionally relied on
sending trained interviewers and nurses on home
visits to these scattered samples living across
England, Scotland and Wales.
Can I get hold of the data? Where
can I find out more?
Facilitated collaborations with the scientific and
data collection teams by bona fide scientists are wel-
come; they are encouraged to become principal or
co-investigators on grants to raise additional funding
for new research projects based on the new data or
samples. In parallel with the data collection, a secure
web-based tool to facilitate working with shared sci-
entific data and resources is being developed.
21
Enquiries should be made to swiftinfo@nshd
.mrc.ac.uk
Through these collaborations, we aim to maximize
the scientific potential of the new data collection.
Supplementary Data
Supplementary data are available at IJE online.
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